EMEA-000639-PIP05-19
Key facts
Invented name |
Ampres
|
Active substance |
Chloroprocaine hydrochloride
|
Therapeutic area |
Anaesthesiology
|
Decision number |
P/0009/2020
|
PIP number |
EMEA-000639-PIP05-19
|
Pharmaceutical form(s) |
Gel
|
Condition(s) / indication(s) |
Ocular surface anaesthesia
|
Route(s) of administration |
Ocular use
|
Contact for public enquiries |
Sintetica GmbH
Tel. +41 916404250
|
Decision type |
RW: decision refers to a refusal on a request for waiver in all age groups for the listed condition(s)
|